Arbutus Biopharma Corporation
ABUS
|
|
| |
|
| Trading Volume | 12,412 |
|
|
3.89 - 1.69 |
| Market Cap Full | $ 643.9M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 4.1% | 3.6% | 30% | -23% |
| Q2 | - | 22% | -24.1% | -9.5% |
| Q3 | - | 1.7% | -11.7% | -29.5% |
| Q4 | - | -11% | 30.2% | 22% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.1 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -5.2 | 18.1 | -7.5 | 5.2 | 23.1 | -7.3 | 21.2 | 1.7 | - | - | - | - |
| 2023 | |||||||||||
| 29.2 | -7.6 | 9 | -17.2 | -0.8 | -7.6 | -5.7 | -6.5 | - | -9.9 | 12 | 22 |
| 2022 | |||||||||||
| -30.1 | 22.4 | -10.1 | -22.2 | 4.3 | 11.5 | -14.8 | -4.6 | -13.4 | 22.5 | 0.4 | -0.9 |
| 2021 | |||||||||||
| 6.5 | -0.8 | -11.2 | 4.2 | -18.4 | 7.1 | -11.2 | 27.5 | 25.1 | -7.2 | -23.1 | 27 |
| 2020 | |||||||||||
| -8.4 | 11.5 | -65.3 | 14.9 | 87.1 | -16.1 | 109.3 | -23.4 | 7.2 | -9.9 | 60.6 | -21.6 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.1 | -0.1 | -0.2 | -0.3 |
| Q2 | -0.1 | -0.1 | -0.2 | -0.3 |
| Q3 | -0.1 | -0.1 | -0.2 | -0.3 |
| Q4 | 0 | -0.1 | -0.2 | -0.2 |
| A | -0.32 | -0.5 | -0.8 | -1 |